Clinical Trial Update: UK Validation of the Automated "AcceXible" Speech Analysis Software

View source ↗

Summary

UK validation study of the AcceXible automated speech analysis software has completed, evaluating its performance in mild cognitive impairment and dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Snippet

Sponsor: Accexible | Conditions: Mild Cognitive Impairment and Dementia | Status: COMPLETED